Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Regional Differences in Baseline Disease Characteristics and Prior Treatment in the ECZTRA 1 and ECZTRA 2 Trials. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Apr. 19];4(6):s101. Available from: https://skin.dermsquared.com/skin/article/view/1078